TrialInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2015

A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study.

Charles Kunos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.